Clinical Trials Directory

Trials / Completed

CompletedNCT04843605

Systematic Screening for COPD in Tabacology Consultation

Impact of Systematic Screening for COPD in Tabacology Consultation

Status
Completed
Phase
Study type
Observational
Enrollment
112 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers

Summary

COPD is a very common disease, an estimated 3 million people are affected in France. Unfortunately, this pathology is under-diagnosed. Several reasons can be mentioned: the banality of the symptoms or the several comorbidities. Screening faces a major difficulty: the realization of a spirometry. Various studies have shown the complexity of the implementation of mass screening in cities by mini-spirometry. The COPD World Health Days allow this mass screening but without visibility on the actual entry into a care pathway. The objective of this study is to assess the impact of systematic screening for COPD during a tabacology consultation

Conditions

Timeline

Start date
2021-05-16
Primary completion
2023-08-01
Completion
2023-08-01
First posted
2021-04-13
Last updated
2024-08-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04843605. Inclusion in this directory is not an endorsement.